I1D Stock Overview
Operates dental hospitals and clinics in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Arrail Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.34 |
| 52 Week High | HK$0.89 |
| 52 Week Low | HK$0.30 |
| Beta | 0.28 |
| 11 Month Change | -5.08% |
| 3 Month Change | -14.29% |
| 1 Year Change | -62.03% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -78.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| I1D | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 2.4% | 2.9% | 1.1% |
| 1Y | -62.0% | 14.9% | 7.2% |
Return vs Industry: I1D underperformed the German Healthcare industry which returned 13.9% over the past year.
Return vs Market: I1D underperformed the German Market which returned 8.6% over the past year.
Price Volatility
| I1D volatility | |
|---|---|
| I1D Average Weekly Movement | 13.8% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: I1D's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: I1D's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 3,464 | Robert Zou | www.arrailgroup.com |
Arrail Group Limited operates dental hospitals and clinics in China. The company offers dental services, such as general dentistry, orthodontics, and implantology. It also engages in the wholesale of medical materials; and hospital management business.
Arrail Group Limited Fundamentals Summary
| I1D fundamental statistics | |
|---|---|
| Market cap | €169.73m |
| Earnings (TTM) | €2.24m |
| Revenue (TTM) | €228.02m |
75.7x
P/E Ratio0.7x
P/S RatioIs I1D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| I1D income statement (TTM) | |
|---|---|
| Revenue | CN¥1.75b |
| Cost of Revenue | CN¥1.35b |
| Gross Profit | CN¥392.68m |
| Other Expenses | CN¥375.51m |
| Earnings | CN¥17.16m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Nov 29, 2024
| Earnings per share (EPS) | 0.038 |
| Gross Margin | 22.49% |
| Net Profit Margin | 0.98% |
| Debt/Equity Ratio | 19.4% |
How did I1D perform over the long term?
See historical performance and comparison